2.99Open2.99Pre Close0 Volume15 Open Interest7.50Strike Price0.00Turnover259.27%IV17.47%PremiumAug 16, 2024Expiry Date1.43Intrinsic Value100Multiplier25DDays to Expiry1.56Extrinsic Value100Contract SizeAmericanOptions Type0.7265Delta0.0546Gamma2.99Leverage Ratio-0.0410Theta0.0024Rho2.17Eff Leverage0.0078Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet